Austedo XR

[anonymous]

Here we are, a month in. Whoa, home office can’t be happy. I have 2 rx’s, our district about 17. Most of my customers reaction to the dosing and titration “well that’s disappointing”. Add that to the Uzedy disaster and as usual, Teva psych/neuro is in a world of hurt.

 

[anonymous]

Here we are, a month in. Whoa, home office can’t be happy. I have 2 rx’s, our district about 17. Most of my customers reaction to the dosing and titration “well that’s disappointing”. Add that to the Uzedy disaster and as usual, Teva psych/neuro is in a world of hurt.

Proves this is just another poser from Neurocrine. What's a district? We don't have those here at Teva. What's wrong loser, are the scripts I'm taking away from your weak ass Ingrezza business getting to you?

 

[anonymous]

Austedo XR is going so well large parts TEVA have instituted travel bans and a hiring freeze.

 

[anonymous]

Proves this is just another poser from Neurocrine. What's a district? We don't have those here at Teva. What's wrong loser, are the scripts I'm taking away from your weak ass Ingrezza business getting to you?

Poser or not, they aren’t wrong.

 

[anonymous]

Teva over the last 3 years has gained ground on Ingrezza. It is very close now. Neurocrine is losing the #1 selling label it always mentioned in commercials.

 

[anonymous]

Teva over the last 3 years has gained ground on Ingrezza. It is very close now. Neurocrine is losing the #1 selling label it always mentioned in commercials.

LMAO. Look at 2022 financials. Look at Q1 2023 financials. But sure, yeah, whatever you say.

 

[anonymous]

LMAO. Look at 2022 financials. Look at Q1 2023 financials. But sure, yeah, whatever you say.

Your first mistake is looking at just q1coverall Financials because neurocrine pull sales from q2 of 2023 on whole sale orders. Teva in q4 pulled sales from q1 2023 in q4 of 2022. Which is why numbers were so low in q1 of 2023. I'm sure you looked closely at the numbers in the financial report. Something tells me you did not dig into the financial and are just parroting something you were told.

 

[anonymous]

Your first mistake is looking at just q1coverall Financials because neurocrine pull sales from q2 of 2023 on whole sale orders. Teva in q4 pulled sales from q1 2023 in q4 of 2022. Which is why numbers were so low in q1 of 2023. I'm sure you looked closely at the numbers in the financial report. Something tells me you did not dig into the financial and are just parroting something you were told.

teva gobs at the glorihole, the only thing Teva is good at

 

[anonymous]

Pasty white Euro-Boy strikes again from his mom's basement.

 

[anonymous]

Pasty white Euro-Boy strikes again from his mom's basement.

Are you wanting the code for the executive g hole?

 

[anonymous]

Pasty white Euro-Boy strikes again from his mom's basement.

Are you sad that you are missing out on the executive fysts ? Perhaps start with some goat action it’ll get you a head at TEVA.

 

[anonymous]

So your Israeli makes sense. Getting closer to finding you Mr. GOAT

 

[anonymous]

Another week, another goose egg for XR scripts. What a joke of a "QD" product and don't get me started this Uzedy debacle.

 

[anonymous]

Another week, another goose egg for XR scripts. What a joke of a "QD" product and don't get me started this Uzedy debacle.

As stated earlier , the only thing Teva is good at is being the master of gloriholes.

 

[anonymous]

Your first mistake is looking at just q1coverall Financials because neurocrine pull sales from q2 of 2023 on whole sale orders. Teva in q4 pulled sales from q1 2023 in q4 of 2022. Which is why numbers were so low in q1 of 2023. I'm sure you looked closely at the numbers in the financial report. Something tells me you did not dig into the financial and are just parroting something you were told.

Ingrezza Q2 $440 million in sales but yeah, Austedo is closing the gap. Take a hike junior.

 

[anonymous]

Ingrezza Q2 $440 million in sales but yeah, Austedo is closing the gap. Take a hike junior.

You know someone is struggling with mental health issues when they go through cafe pharma posts to say something. Whoever posted the original comment really got under your skin.

 

[anonymous]

Austedo is going great. We’ll overtake Ingressa this year.

 

[anonymous]

Austedo is going great. We’ll overtake Ingressa this year.

Ingressa? GTFOH, hahahahaha!

 

[anonymous]

Ingressa? GTFOH, hahahahaha!

Neurocrine is panicking

 

[anonymous]

Neurocrine is panicking

Panicking at the hole of glor-ious ?